Christopher Hentschel
A bio-pharmaceutical executive with more than 25 years’ international R&D and technology transfer management experience in both private and public sectors. Doctorate in biochemistry, King’s College, London. Early career focused on basic biomedical research, including as a Fogarty Fellow at NIH, USA. Serves as an alternate Member of the Roll Back Malaria (RBM) Partnership Executive Committee, representing the product development constituency. CEO of MMV since 2000 but stepping down in 2010 -see www.mmv.org